The small South San Francisco company and the Big Biotech player had different objectives when they reworked their three-year-old deal. But that's OK, says the local company's CEO.
The small South San Francisco company and the Big Biotech player had different objectives when they reworked their three-year-old deal. But that's OK, says the local company's CEO.